Aldeyra Therapeutics, Inc. (ALDX)
0.6703
-0.06
(-8.72%)
USD |
NASDAQ |
Oct 21, 16:00
0.6658
0.00 (0.00%)
After-Hours: 20:00
Aldeyra Therapeutics Net Income (Annual) : -33.85M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -33.85M |
| December 31, 2024 | -55.85M |
| December 31, 2023 | -37.54M |
| December 31, 2022 | -62.02M |
| December 31, 2021 | -57.78M |
| December 31, 2020 | -37.55M |
| December 31, 2019 | -60.83M |
| December 31, 2018 | -38.89M |
| Date | Value |
|---|---|
| December 31, 2017 | -22.34M |
| December 31, 2016 | -18.70M |
| December 31, 2015 | -12.09M |
| December 31, 2014 | -5.187M |
| December 31, 2013 | 12.24M |
| December 31, 2012 | -23.46M |
| December 31, 2011 | -2.593M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Prime Medicine, Inc. | -201.14M |
| Arrowhead Pharmaceuticals, Inc. | 30.11M |
| Oncolytics Biotech, Inc. | -28.76M |
| Sangamo Therapeutics, Inc. | -122.93M |
| Sarepta Therapeutics, Inc. | -713.41M |